Addi🌊🐢☀️ :
No, that logic is fundamentally incorrect and potentially dangerous.
While the speaker in the video attempts to draw a parallel to how medical anesthesia or standard medications are dosed by weight, research peptides and experimental compounds do not work that way.
Why Body-Weight Dosing Doesn't Apply Here
Pharmacokinetics vs. Receptor Saturation: Anesthesia works by circulating in the blood to depress the central nervous system based on total body mass and blood volume. In contrast, many peptides (such as growth hormone secretagogues or metabolic research compounds) bind to specific cellular receptors. Their efficacy and safety thresholds are dictated by receptor saturation points, not a linear scaling of body weight.
Risk of Toxicity and Adverse Effects: Scaling certain peptides up for a higher body weight can easily push a user past safe pharmacological thresholds. As the speaker briefly notes at the end of the clip, compounds like MOTS-c, Ratatouille (retatrutide), or GLP receptor agonists directly impact metabolic pathways and heart rates. Overdosing these compounds based on weight can lead to severe side effects, including dangerous cardiovascular strain, extreme tachycardia, gastrointestinal distress, or profound hypoglycemia.
Lack of Standardized Human Guidelines: Because these compounds are sold strictly as research chemicals and are not approved for human consumption, there are no clinically validated, weight-based dosing charts backed by FDA human clinical trials. Guessing a dose based on body weight offers zero actual safety guarantees.
2026-08-22 19:26:29